Corporate News

Symposium on consistency evaluation and BE of inhaled generic drugs by IDDA

文章更新:贝诺康医药   更新时间:2019年04月20日   分享到:

The company participated in the "consistency evaluation and BE study of inhaled generic drug" academic workshop hosted by the national inhalation drug delivery Consortium (IDDA) in Beijing On April 20, 2019.The meeting invited a number of prominent experts from domestic and abroad to conduct discussions on the latest industry trends, edge technologies and clinical encounters which involved addressing experience sharing and problem solving in the evaluation of the consistency of inhaled drug delivery generics, introduction to novel inhalation drug delivery devices and new inhalation drug delivery technology changes the administration route of mature drug products and new molecular delivery route…etc, the company widely communicated with many industry experts and peers.